Trials / Completed
CompletedNCT04721808
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
Treatment Patterns and 6 and 12-Month Effectiveness of Tofacitinib in the Corrona Rheumatoid Arthritis Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,712 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is to investigate and describe the treatment patterns and effect of tofacitinib indicators for patients with Rheumatoid Arthritis (RA) assessing real world patient data entered in the Corrona RA Registry on or after November 2012
Conditions
Timeline
- Start date
- 2021-01-22
- Primary completion
- 2021-11-24
- Completion
- 2021-11-24
- First posted
- 2021-01-25
- Last updated
- 2023-09-29
- Results posted
- 2023-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04721808. Inclusion in this directory is not an endorsement.